Hyperphosphatemia
📧 Sign up to get email alerts when something new happens for Hyperphosphatemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis [Phase 3]
Phase 3 trial update for KHK7791 in hyperphosphatemia patients on peritoneal dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]
Phase 3 trial update for KHK7791 phosphate binder combo in hyperphosphatemia patients on hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]
A Phase 3 clinical trial evaluating KHK7791 in patients with hyperphosphatemia on hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating tolerance, pharmacodynamics, and pharmacokinetics of lanthanum polystyrene sulfonate powder for hyperpho…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: PA21 Safety and Efficacy in Adult Chinese Subjects [Phase 3]
Phase 3 clinical trial update evaluating PA21 safety and efficacy in adult Chinese subjects with chronic kidney disease on dialysis and hype…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis [Phase 3]
A Phase 3 clinical trial evaluating ferric citrate for treating hyperphosphatemia in patients with chronic kidney disease on hemodialysis ha…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia [Phase 4]
A Phase 4 trial comparing lanthanum versus calcium carbonate for vascular abnormalities in patients with chronic kidney disease and hyperpho…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients [Phase 3]
Phase 3 trial comparing placebo to SBR759 for lowering phosphate in dialysis patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis [Phase 2]
Phase 2 trial update on SBR759 showing efficacy in lowering serum phosphate in chronic kidney disease patients on hemodialysis.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients [Phase 2]
A Phase 2 clinical trial comparing chewed versus crushed lanthanum carbonate in hemodialysis patients with hyperphosphatemia has completed, …
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD) [Phase 3]
A Phase 3 trial evaluating tenapanor for hyperphosphatemia in ESRD patients on hemodialysis has completed and posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China [Phase 3]
A Phase 3 trial evaluating Renvela for hyperphosphatemia in chronic kidney disease patients not on dialysis in China has completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis [Phase 4]
Phase 4 trial assessing safety and efficacy of Nephoxil® in subjects with end-stage renal disease on dialysis.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease [Phase 3]
Phase 3 randomized trial evaluating ferric citrate in subjects with hyperphosphatemia and end-stage renal disease (ESRD) has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis [Phase 2]
Phase 2 trial assessing pharmacokinetics and comparing lanthanum carbonate to calcium carbonate for efficacy and safety in hyperphosphatemic…
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia [Phase 3]
A Phase 3 pediatric CKD trial comparing Velphoro (PA21) and Phoslyra (calcium acetate) for hyperphosphatemia was terminated with results pos…
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia [Phase 3]
Phase III study of PA21 in hemodialysis patients with hyperphosphatemia has completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia [Phase 3]
Phase III trial update for PA21 with calcium carbonate in hemodialysis patients with hyperphosphatemia; study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D [Phase 3]
Phase 3 trial update for ferric citrate in transitioning from CKD stages 4/5 to 5D; study completed.
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Behavioral Management of Phosphorus in Hemodialysis Patients [NA]
This clinical trial update reports completion of a study evaluating behavioral strategies to manage phosphorus levels in hemodialysis patien…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients [NA]
Clinical trial update indicating the study on individualized therapy for hyperphosphatemia in maintenance hemodialysis patients has complete…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Hyperphosphatemia in Children With Chronic Kidney Disease [Phase 3]
Phase 3 clinical trial update examining hyperphosphatemia in children with chronic kidney disease; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-06-21Clinical Trial Update: The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan [NA]
A terminated clinical trial evaluated whether sevelamer carbonate (Renvela) reduces atherosclerotic plaque inflammation in dialysis patients…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis [Phase 4]
Phase 4 clinical trial assessing the efficacy of niacin for hyperphosphatemia in patients undergoing haemodialysis. The current status of th…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease [Phase 2]
This document summarizes a Phase 2 efficacy and safety study of sevelamer carbonate in hyperphosphatemic pediatric participants with chronic…